Emerging Roles for VEGF-D in Human Disease.

about

Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.Growth and Immune Evasion of Lymph Node Metastasis.

P2860

Q50419857-D33259E5-63BC-4662-93D3-0D19394E0C20 Q54958616-2C7E2DC3-3EBC-44B3-AF91-3BBA8796755A Q55364617-3B06F639-57FC-4059-8750-9E026B0FB647

P2860

Emerging Roles for VEGF-D in Human Disease.

Item

http://www.wikidata.org/entity/Q47233157

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Emerging Roles for VEGF-D in Human Disease.

@en

Emerging Roles for VEGF-D in Human Disease.

@nl

type

Item

label

Emerging Roles for VEGF-D in Human Disease.

@en

Emerging Roles for VEGF-D in Human Disease.

@nl

prefLabel

Emerging Roles for VEGF-D in Human Disease.

@en

Emerging Roles for VEGF-D in Human Disease.

@nl

P1476

Emerging Roles for VEGF-D in Human Disease.

@en

P2093

Marc G Achen

http://www.w3.org/2001/XMLSchema#string

Steven A Stacker

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Aspirin intake and survival after breast cancer

Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

P31

scholarly article

review article

P356

10.3390/BIOM8010001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven A Stacker

Marc G Achen

P5008

ScienceSource

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29300337

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

peptide

lung disease

cardiovascular disease

lymphatic system disease

P932

5871970

http://www.w3.org/2001/XMLSchema#string

Emerging Roles for VEGF-D in Human Disease.

about

P2860

P2860

Emerging Roles for VEGF-D in Human Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932